ROSSI, VIRGINIA
 Distribuzione geografica
Continente #
NA - Nord America 721
AS - Asia 656
EU - Europa 600
SA - Sud America 63
Continente sconosciuto - Info sul continente non disponibili 22
AF - Africa 11
OC - Oceania 6
Totale 2.079
Nazione #
US - Stati Uniti d'America 689
RU - Federazione Russa 231
CN - Cina 204
SG - Singapore 189
IT - Italia 171
HK - Hong Kong 69
KR - Corea 54
BR - Brasile 50
VN - Vietnam 47
IE - Irlanda 35
DE - Germania 26
FI - Finlandia 25
FR - Francia 23
SE - Svezia 23
BD - Bangladesh 21
CA - Canada 20
IN - India 20
GB - Regno Unito 17
CH - Svizzera 14
JO - Giordania 11
NL - Olanda 11
ID - Indonesia 10
JP - Giappone 10
ES - Italia 8
AU - Australia 6
MX - Messico 6
AR - Argentina 5
AT - Austria 4
BJ - Benin 4
EC - Ecuador 4
IQ - Iraq 4
NG - Nigeria 4
NO - Norvegia 3
SA - Arabia Saudita 3
CL - Cile 2
CZ - Repubblica Ceca 2
KW - Kuwait 2
MY - Malesia 2
OM - Oman 2
PL - Polonia 2
TH - Thailandia 2
UA - Ucraina 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
CO - Colombia 1
CR - Costa Rica 1
GT - Guatemala 1
HN - Honduras 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
PA - Panama 1
PK - Pakistan 1
PY - Paraguay 1
QA - Qatar 1
TJ - Tagikistan 1
TN - Tunisia 1
TR - Turchia 1
Totale 2.057
Città #
Santa Clara 169
Singapore 142
Ashburn 134
Hefei 77
Hong Kong 61
Seoul 54
San Jose 40
Dublin 35
Rome 27
Florence 24
Los Angeles 22
Council Bluffs 21
Beijing 20
Dallas 20
Helsinki 19
Boardman 17
Ho Chi Minh City 17
Munich 17
Milan 15
Buffalo 14
Chandler 14
Bern 13
New York 11
Fairfield 9
Lauterbourg 9
São Paulo 9
The Dalles 9
Tokyo 9
Houston 8
Moscow 8
Kent 7
Hanoi 6
Jakarta 6
Melbourne 6
Montreal 6
Paris 6
Shanghai 6
Bengaluru 5
Mexico City 5
Mumbai 5
Orem 5
Woodbridge 5
Abuja 4
Acton 4
Altamura 4
Amsterdam 4
Brescia 4
Cotonou 4
Frankfurt am Main 4
Haiphong 4
Lappeenranta 4
Lawrence 4
London 4
Pune 4
Seattle 4
Stockholm 4
Venice 4
Wilmington 4
Ann Arbor 3
Boston 3
Cambridge 3
Catania 3
Da Nang 3
Miami 3
Naples 3
Newark 3
Oslo 3
Shenzhen 3
Vienna 3
A Coruña 2
Agliana 2
As Sālimīyah 2
Baghdad 2
Birigui 2
Bologna 2
Calcinaia 2
Chennai 2
Chicago 2
Dedham 2
Delhi 2
Denver 2
Figino 2
Giugliano in Campania 2
Guangzhou 2
Hangzhou 2
Harringay 2
Hillsboro 2
Jacksonville 2
Johannesburg 2
Kowloon City 2
Lake Park 2
Madrid 2
Manchester 2
Marseille 2
Messina 2
Miano 2
Phoenix 2
Piscataway 2
Poplar 2
Princeton 2
Totale 1.271
Nome #
Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer 247
A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy 219
Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes 183
Retrospective analysis of 77 patients with ovarian cancer undergoing genetic testing for BRCA1 and BRCA2 mutations 182
Analysis of molecular and clinical markers of resistance to bacillus of Calmette-Guérin immunotherapy in patients with urothelial non-muscle invasive bladder cancer 179
Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on Survival 178
Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice 173
Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25) 171
Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors 167
Hypoxia-Inducible Factor in Renal Cell Carcinoma: From Molecular Insights to Targeted Therapies 148
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis 97
A Snapshot from the Italian Clinical Practice Regarding Efficacy and Utility Rate of Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: The RealBLADDER Study 61
Real-world effectiveness of Avelumab maintenance in advanced urothelial carcinoma: results from the Italian multicenter MALVA study (Meet-URO 25) 39
Overlapping Extremes: An Analysis of Avelumab Maintenance and Pembrolizumab in Advanced Urothelial Carcinoma 35
Totale 2.079
Categoria #
all - tutte 6.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.659


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202215 0 0 1 1 2 1 0 1 0 1 5 3
2022/2023125 3 13 3 9 7 25 16 13 16 1 4 15
2023/2024105 5 5 8 9 11 18 9 13 1 8 2 16
2024/2025636 18 54 35 108 139 85 15 25 42 25 32 58
2025/20261.104 128 139 143 114 108 28 108 62 72 71 54 77
2026/202754 39 15 0 0 0 0 0 0 0 0 0 0
Totale 2.079